SG Americas Securities, LLC
Broker-DealerPosition in NTLA — Intellia Therapeutics, Inc.
CIK 1313360
NEW YORK, NY
Position in NTLA
as of Mar 31, 2026
· filed Apr 16, 2026
Position Value
$1,149,800
+$492,245 QoQ
Shares Held
89,688
+22.6% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SG Americas Securities, LLC holds $695,801,470 across 175 Biotechnology names. NTLA ranks #60 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
158,278 | $122,291,913 | |
| 2 | PTCT |
Ptc Therapeutics, Inc.
|
879,701 | $59,934,029 | |
| 3 | HRMY |
Harmony Biosciences Holdings, Inc.
|
2,018,174 | $56,529,053 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
199,705 | $37,754,230 | |
| 5 | URGN |
UroGen Pharma Ltd.
|
1,657,846 | $29,808,071 | |
| 6 | ASND |
Ascendis Pharma A/S
|
120,790 | $27,628,296 | |
| 7 | INCY |
Incyte Corp
|
285,152 | $26,838,506 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
56,982 | $25,444,742 |
All Filings in NTLA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,149,800 | 89,688 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $657,555 | 73,143 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $2,263,578 | 131,070 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $361,927 | 38,585 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $294,617 | 41,437 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $522,811 | 44,838 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $496,159 | 24,144 | Shares | Sole | 2024-10-03 | |
| 2024-06-30 | $138,688 | 6,197 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $160,410 | 5,831 | Shares | Sole | 2024-05-06 | |
| 2023-06-30 | $389,530 | 9,552 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $752,071 | 20,179 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $696,404 | 19,960 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $608,956 | 10,882 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $363,303 | 7,019 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $1,586,604 | 21,833 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $3,765,944 | 31,850 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $1,948,797 | 14,527 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $1,633,186 | 10,087 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $905,757 | 11,286 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $333,852 | 6,137 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $787,188 | 39,597 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $723,655 | 34,427 | Shares | Sole | 2020-07-20 | |
| No filing history on record for this holder in this stock. | ||||||